SCHEMBL7218372

SCHEMBL7218372

CC(=NCCCC(N)C(=O)c1ncc[nH]1)NO

nearest known ligand 0.54

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NOS1 P29475 8/20 0.37
NOS3 P29474 5/20 0.37
NOS2 P35228 7/20 0.36
CYP2C19 P33261 3/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
HRH4 Q9H3N8 2/20 0.33
FURIN P09958 1/20 0.33
CYP1A2 P05177 2/20 0.33
TSHR P16473 2/20 0.33
CYP3A4 P08684 1/20 0.33
DDAH1 O94760 2/20 0.32
NPC1 O15118 1/20 0.32
RAB9A P51151 1/20 0.32
BLM P54132 1/20 0.32
GLA P06280 1/20 0.32
NFKB1 P19838 1/20 0.32
APEX1 P27695 1/20 0.32
THPO P40225 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7218366 0.80 NPC1 (0.33) MEN1KMT2ANPC1RAB9A
SCHEMBL7218361 0.80 NPC1 (0.33) MEN1KMT2ANPC1RAB9A
SCHEMBL28044670 0.75 GSR (0.43) KMT2ANPC1RAB9A
SCHEMBL28612372 0.67 NPC1 (0.46) KMT2ANPC1RAB9AGLA
SCHEMBL11599997 0.67 NPC1 (0.46) KMT2ANPC1RAB9AGLA
Hydrochloric Acid SCHEMBL17275456 0.65 NPC1 (0.45) KMT2ANPC1RAB9AGLA
Hydrochloric Acid SCHEMBL17275457 0.65 NPC1 (0.45) KMT2ANPC1RAB9AGLA
SCHEMBL10615777 0.65 CA2 (0.43) CYP2C19MEN1KMT2ACYP1A2TSHR
SCHEMBL10617270 0.64 NPC1 (0.41) CYP2C19KMT2ACYP1A2TSHRCYP3A4
SCHEMBL6666888 0.63 NPC1 (0.49) KMT2ANPC1RAB9AGLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6576780-B1 Hydroxyamidino derivatives useful as nitric oxide synthase inhibitors GD SEARLE & COMPANY 2003-06-10 US claimed
US-6576780-B1 Hydroxyamidino derivatives useful as nitric oxide synthase inhibitors GD SEARLE & COMPANY 2003-06-10 US disclosed
US-6207708-B1 FOR THERAPY AND PROPHYLAXIS OF AUTOIMMUNE AND/OR INFLAMMATORY CONDITIONS AFFECTING THE JOINTS SUCH AS ARTHRITIS, AND INFLAMMATORY BOWEL DISEASE, CARDIVASCULAR ISCHEMIA, DIABETES, CONGESTIVE HEART FAILURE, MYOCARDITIS, ATHEROSCLEROSIS, G. D. SEARLE & COMPANY 2001-03-27 US disclosed